Recognizing that many healthcare systems today are challenged to maintain quality across a wide range of patient and exam types, MyoSPECT also includes several new automated features to help expedite workflows and make it easy to achieve quality results consistently.

To start, the system's new Smart Positioning solution offers scan positioning prompts and extended field-of-view recommendations to optimize patient positioning. Then, MyoSPECT leverages device-less Alcyone Motion Detection and Correction on Xeleris – GE Healthcare's processing and review solution – to generate images without motion to view cardiac anatomy and pathology with fewer artifacts and great clarity. The system also includes SPECT Flow, which combines dynamic acquisition on MyoSPECT with coronary flow reserve (CFR) and absolute myocardial blood flow, should clinicians wish to use an external CT for attenuation correction[v]. This process delivers valuable insight into each patient's blood flow for true dynamic cardiac imaging and great diagnostic confidence.


Finally, the system offers clinicians two options for attenuation correction and evaluation – both of which have the added benefit of excellent CZT resolution:

Correct attenuation by combining perfusion images with separate CT images on Xeleris; or
Evaluate attenuation artifacts by imaging both prone and supine positions without additional radiation exposure since MyoSPECT uses a table for patient positioning.

Altogether, the system is designed to view cardiac anatomy and pathology with great clarity, exceptional patient comfort, and provide clinicians with the information they need to help improve patient outcomes.

GE Healthcare will be showcasing the next generation nuclear medicine cardiac system at the 26th Annual Scientific Session and Expedition of the American Society of Nuclear Cardiology.

Back to HCB News

Cardiology Homepage